Published Year: 2018
Global Image Guided Interventional Systems Market - Analysis and Forecast, 2018-2028: Focus on Produ
The global image guided interventions market is expected to reach $6,509.3 million by...
Market Research Report
A quick peek into the report
Table of Contents
1.1 Types of Interventional Cardiology Procedures
1.2 Devices Used in Interventional Cardiology
2.1 Overview
2.2 Market Drivers
2.2.1 Rising Geriatric Population Due to Higher Life Expectancy
2.2.2 Increasing Clinical Evidence of Effectiveness of Advanced Interventional Cardiac Devices
2.2.3 Technological Advancements in Interventional Cardiac Devices
2.2.4 Growing Healthcare Budgetary Allocation in Emerging Economies
2.2.5 Increasing Awareness about Minimally Invasive Surgical Procedure among Patients
2.3 Market Restraints
2.3.1 Stringent Regulatory Requirements for Product Approval and Insufficient Reimbursement Policies
2.3.2 Complications and Risks Associated with the Use of Interventional Cardiac Devices
2.3.3 High Cost of Interventional Cardiology Procedures
2.4 Market Opportunities
2.4.1 Growing Awareness about Advanced Interventional Cardiac Devices
2.4.2 Global Shift toward Value-based Care (VBC)
2.4.3 Increasing Adoption of Innovative Treatment Technologies
2.4.4 Evolving Competitive Landscape of Cardiac Interventions Market
3.1 Definition of Medical Devices
3.2 Framework for Medical Device Regulations
3.2.1 Medical Devices Reporting (MDR)
3.2.2 China Food and Drug Administration (CFDA) Guidelines for Medical Devices
3.2.3 Recommendations for IVUS, FFR, and OCT by Various Cardiology Societies
3.3 Patent Landscape
4.1 Key Developmental Strategies
4.1.1 Product Approval
4.1.2 Clinical Study
4.1.3 Product Launch
4.1.4 Acquisitions
4.1.5 Partnership, Agreement, Joint Venture, and Collaboration
4.1.6 Business Expansion
4.1.7 Awards and Recognition
4.1.8 Others
4.2 Market Share Analysis
4.2.1 Market Share for Interventional Cardiology Market for Conventional Devices
4.2.2 Global Optical Coherent Tomography (OCT) Market Share
4.2.3 Global IVUS Market Share
5.1 Global Interventional Cardiology Market (by Conventional Device)
5.1.1 Cardiac Catheters
5.1.2 PTCA Balloons
5.1.3 Coronary Stents
5.1.4 Cardiac Valves
5.1.5 Others
5.2 Global Interventional Cardiology Market (by Advanced Device)
5.2.1 Intravascular Ultrasound (IVUS)
5.2.2 Fractional Flow Reserve (FFR)
5.2.3 Optical Coherence Tomography (OCT)
6.1 Hospitals
6.2 Cardiac Catheterisation Laboratories
6.3 Ambulatory Surgical Centres
6.4 Others
7.1 North America
7.1.1 The U.S.
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 The U.K.
7.2.4 Italy
7.2.5 Spain
7.2.6 The Netherlands
7.2.7 Switzerland
7.2.8 Belgium
7.2.9 Sweden
7.2.10 Austria
7.2.11 Rest-of-Europe
7.3 Asia-Pacific
7.3.1 Japan
7.3.2 China
7.3.3 South Korea
7.3.4 Australia
7.3.5 India
7.3.6 Malaysia
7.3.7 Singapore
7.3.8 Taiwan
7.3.9 Rest-of-Asia-Pacific
7.4 Latin America
7.4.1 Brazil
7.4.2 Mexico
7.4.3 Rest-of-Latin America
7.5 Rest-of-the-World (RoW)
7.5.1 Russia
7.5.2 Kingdom of Saudi Arabia (K.S.A.)
7.5.3 South Africa
7.5.4 Others
8.1 ABIOMED, Inc.
8.1.1 Company Overview
8.1.2 Product Offerings for Cardiac Interventions
8.1.3 Financials
8.1.3.1 Financial Summary
8.1.4 Global Presence
8.1.5 Recent Developments
8.1.6 SWOT Analysis
8.2 ACIST Medical Systems, Inc.
8.2.1 Company Overview
8.2.2 Product Offerings for Cardiac Interventions
8.2.3 Corporate Summary
8.2.4 Recent Developments
8.2.5 SWOT Analysis
8.3 B. Braun Melsungen AG
8.3.1 Company Overview
8.3.2 Overall Product Portfolio
8.3.2.1 Product Offerings for Cardiac Interventions
8.3.3 Financials
8.3.3.1 Financial Summary
8.3.4 Global Presence
8.3.5 Recent Developments
8.3.6 SWOT Analysis
8.4 Biotronik SE & Co. KG
8.4.1 Company Overview
8.4.2 Overall Product Portfolio
8.4.2.1 Product Offerings for Cardiac Interventions
8.4.3 Corporate Summary
8.4.4 Global Presence
8.4.5 SWOT Analysis
8.5 Boston Scientific Corporation
8.5.1 Company Overview
8.5.2 Overall Product Portfolio
8.5.2.1 Product Offerings for Cardiac Interventions
8.5.3 Financials
8.5.3.1 Financial Summary
8.5.4 Global Presence
8.5.5 Recent Developments
8.5.6 SWOT Analysis
8.6 C. R. Bard, Inc.
8.6.1 Company Overview
8.6.2 Becton, Dickinson and Company: Company Overview
8.6.3 Overall Product Portfolio
8.6.3.1 Product Offerings for Cardiac Interventions
8.6.4 Financials
8.6.4.1 Financial Summary
8.6.5 Global Presence
8.6.6 Recent Developments
8.6.7 SWOT Analysis
8.7 Cook Medical LLC
8.7.1 Company Overview
8.7.2 Overall Product Portfolio
8.7.2.1 Product Offerings for Cardiac Interventions
8.7.3 Corporate Summary
8.7.4 Global Presence
8.7.5 Recent Developments
8.7.6 SWOT Analysis
8.8 Cordis Corporation
8.8.1 Company Overview
8.8.2 Cardinal Health, Inc.: Company Overview
8.8.3 Overall Product Portfolio
8.8.3.1 Product Offerings for Cardiac Interventions
8.8.4 Financials
8.8.4.1 Financial Summary
8.8.5 Global Presence
8.8.6 Recent Developments
8.8.7 SWOT Analysis
8.9 Edwards Lifesciences Corporation
8.9.1 Company Overview
8.9.2 Overall Product Portfolio
8.9.3 Product Offerings for Cardiac Interventions
8.9.4 Financials
8.9.4.1 Financial Summary
8.9.5 Global Presence
8.9.6 Recent Developments
8.9.7 SWOT Analysis
8.10 Life Vascular Devices Biotech S.L.
8.10.1 Company Overview
8.10.2 Overall Product Portfolio
8.10.2.1 Product Offerings for Cardiac Interventions
8.10.3 Corporate Summary
8.10.4 Recent Developments
8.10.5 SWOT Analysis
8.11 Biosense Webster, Inc
8.11.1 Company Overview
8.11.2 Johnson & Johnson Services, Inc.: Company Overview
8.11.3 Overall Product Portfolio
8.11.3.1 Product Offerings for Cardiac Interventions
8.11.4 Financials
8.11.4.1 Financial Summary
8.11.5 Global Presence
8.11.6 Recent Developments
8.11.7 SWOT Analysis
8.12 Medtronic Plc
8.12.1 Company Overview
8.12.2 Overall Product Portfolio
8.12.2.1 Product Offerings for Cardiac Interventions
8.12.3 Financials
8.12.3.1 Financial Summary
8.12.4 Global Presence
8.12.5 Recent Developments
8.12.6 SWOT Analysis
8.13 Merit Medical Systems, Inc
8.13.1 Company Overview
8.13.2 Overall Product Portfolio
8.13.2.1 Product Offerings for Cardiac Interventions
8.13.3 Financials
8.13.3.1 Financial Summary
8.13.4 Global Presence
8.13.5 Recent Developments
8.13.6 SWOT Analysis
8.14 Novacam Technologies Inc.
8.14.1 Company Overview
8.14.2 Overall Product Portfolio
8.14.2.1 Product Offerings for Cardiac Interventions
8.14.3 Corporate Summary
8.14.4 Global Presence
8.14.5 SWOT Analysis
8.15 Koninklijke Philips N.V.
8.15.1 Company Overview
8.15.2 Overall Product Portfolio
8.15.2.1 Product Offerings for Cardiac Interventions
8.15.3 Financials
8.15.3.1 Financial Summary
8.15.4 Global Presence
8.15.5 Recent Developments
8.15.6 SWOT Analysis
8.16 St. Jude Medical
8.16.1 Company Overview
8.16.2 Abbott Laboratories: Company Overview
8.16.3 Overall Product Portfolio
8.16.3.1 Product Offerings for Cardiac Interventions
8.16.4 Financials
8.16.4.1 Financial Summary
8.16.5 Global Presence
8.16.6 Recent Developments
8.16.7 SWOT Analysis
8.17 Terumo Corporation
8.17.1 Company Overview
8.17.2 Overall Product Portfolio
8.17.2.1 Product Offerings for Cardiac Interventions
8.17.3 Financials
8.17.3.1 Financial Summary
8.17.4 Global Presence
8.17.5 Recent Developments
8.17.6 SWOT Analysis
8.18 W. L. Gore & Associates, Inc.
8.18.1 Company Overview
8.18.2 Overall Product Portfolio
8.18.2.1 Product Offerings for Cardiac Interventions
8.18.3 Corporate Summary
8.18.4 Global Presence
8.18.5 Recent Developments
8.18.6 SWOT Analysis
8.19 Biosensors International Group, Ltd.
8.19.1 Company Overview
8.19.2 Product Offerings for Cardiac Interventions
8.20 GE Healthcare
8.20.1 Company Overview
8.20.2 Product Offerings for Cardiac Interventions
9.1 Scope of the Report
9.2 Global Interventional Cardiology Market Segmentation
9.3 Research Methodology
9.3.1 Primary Research
9.3.2 Secondary Research
9.3.3 Key Data Points from Primary and Secondary Sources
9.3.4 Data Triangulation
9.3.5 Top-Down Approach
9.3.6 Bottom- Up Approach
9.4 Assumptions and Limitations
Table 2.1 Market Drivers – Impact Analysis
Table 2.2 Healthcare Expenditure (by Country), $Billion
Table.2.3 Market Challenges – Impact Analysis
Table 2.4 Comparison of Cardiac Procedure Cost between Major Countries
Table 2.5 Market Opportunities – Impact Analysis
Table 3.1 Regulatory Tools and General Requirements of the Five Members of the GHTF
Table 3.2 CFDA Premarket Overview
Table 5.1 Average Procedural Cost of Catheter Ablation
Table 5.2 Safety and Effectiveness of Catheter Ablation
Table 5.3 List of Partially Bioresorbable Coronary Stents
Table 5.4 List of Fully Bioresorbable Coronary Stents
Table 5.5 Average Selling Price of Stents (by Country)
Table 5.6 FDA Approved Stents, 2017
Table 5.7 Average Selling Price of Cardiac Valves (by Company)
Table 5.8 Average Selling Price of Tissue Heart Valves (by Company)
Table 5.9 Average Selling Price (ASP) of Mechanical Heart Valves (by Company)
Table 8.1 ABIOMED, Inc.: Recent Developments
Table 8.2 ACIST Medical Systems, Inc.: Recent Developments
Table 8.3 B. Braun Melsungen AG: Recent Developments
Table 8.4 Biotronik SE & Co. KG: Recent Developments
Table 8.5 Boston Scientific Corporation: Recent Developments
Table 8.6 Becton, Dickinson and Company: Recent Developments
Table 8.7 Cook Medical LLC: Recent Developments
Table 8.8 Cardinal Health, Inc.: Recent Developments
Table 8.9 Edwards Lifesciences Corporation: Recent Developments
Table 8.10 Life Vascular Devices Biotech S.L.: Recent Developments
Table 8.11 Biosense Webster (JnJ): Recent Developments
Table 8.12 Medtronic Plc: Recent Developments
Table 8.13 Merit Medical Systems, Inc: Recent Developments
Table 8.14 Koninklijke Philips N.V.: Recent Developments
Table 8.15 St. Jude Medical (Abbott): Recent Developments
Table 8.16 Terumo Corporation: Recent Developments
Table 8.16 W. L. Gore & Associates, Inc.: Recent Developments
Figure 1 Global Interventional Cardiology Market, $Billion, 2017-2027
Figure 2 Global Interventional Cardiology Market (by Device), 2017 and 2027
Figure 3 Global Conventional Interventional Cardiology Device Market (by Product), 2017 and 2027
Figure 4 Global Advanced Interventional Cardiology Device Market (by Product), 2017 and 2027
Figure 5 Global Interventional Cardiology Market (by End User), 2017 and 2027
Figure 6 Global Interventional Cardiology Market (by Region), 2017 and 2027
Figure 1.1 Number of Patients Diagnosed With Diabetes, Globally, 2000 and 2030
Figure 1.2 Global Interventional Cardiology Market, 2017 and 2027
Figure 2.1 Market Dynamics
Figure 2.2 Steps for U.S. FDA Pre-Market Approval
Figure 3.1 Ideal Conditions for Ensuring Safety and Performance of Medical Devices
Figure 3.2 Share of Patents (by Company)
Figure 4.1 Share of Key Developmental Strategies, January 2015-May 2018
Figure 4.2 Share of Product Approval (by Company), January 2015-May 2018
Figure 4.3 Share of Clinical Study (by Company), January 2015-May 2018
Figure 4.4 Share of Product Launch (by Company), January 2015-May 2018
Figure 4.5 Share of Acquisitions (by Company), January 2015-May 2018
Figure 4.6 Share of Partnership, Agreement, Joint Venture, and Collaboration (by Company), January 2015-May 2018
Figure 4.7 Share of Business Expansion (by Company), January 2015-May 2018
Figure 4.8 Share of Clinical Study (by Company), January 2015-May 2018
Figure 4.9 Share of Other Strategy (by Company), January 2015-May 2018
Figure 4.10 Market Share for Global Interventional Cardiology Market, 2016 and 2017
Figure 4.11 Market Share for Global OCT Devices Market, 2016 and 2017
Figure 4.12 Market Share for Global IVUS Market, 2016 and 2017
Figure 5.1 Global Interventional Cardiology Market
Figure 5.2 Global Interventional Cardiology Market (by Device), 2017-2027
Figure 5.3 Global Interventional Cardiology Market (by Conventional Device), 2018-2027
Figure 5.4 Global Cardiac Catheter Market, 2017-2027
Figure 5.5 Types of Cardiac Conventional Catheters
Figure 5.6 Global Cardiac Catheter Market (by Product), 2017-2027
Figure 5.7 Global PTCA Balloons Market, 2017-2027
Figure 5.8 Global PTCA Balloons Market (by Type), 2017-2027
Figure 5.9 Global Coronary Stents Market, 2017-2027
Figure 5.10 Types of Coronary Stents
Figure 5.11 Global Coronary Stents Market (by Type), 2017-2027
Figure 5.12 Global Cardiac Valves Market, 2017-2027
Figure 5.13 Types of Cardiac Valves
Figure 5.14 Global Cardiac Valves Market (by Type), 2017-2027
Figure 5.15 Global Coronary Guidewire Market, 2017-2027
Figure 5.16 Global Arteriotomy Closure Devices Market, 2017-2027
Figure 5.17 Global Balloon Inflation Devices Market, 2017-2027
Figure 5.18 Global Advanced Cardiac Interventions Market
Figure 5.19 Global Interventional Cardiology Market (by Advanced Device), 2017-2027
Figure 5.20 Global Intravascular Ultrasound (IVUS) Market, 2017-2027
Figure 5.21 Global Intravascular Ultrasound (IVUS) Market (by Component), 2017-2027
Figure 5.22 Global Fraction Flow Reserve (FFR) Market, 2017-2027
Figure 5.23 Global Fractional Flow Reserve (FFR) Market (by Component), 2017-2027
Figure 5.24 Global Optical Coherence Tomography (OCT) Market, 2017-2027
Figure 5.25 Global Optical Coherent Tomography (OCT) Market (by Component), 2017-2027
Figure 6.1 Global Interventional Cardiology Market (by End User)
Figure 6.2 Global Interventional Cardiology Market (by End User), $Million, 2017-2027
Figure 6.3 Hospitals Interventional Cardiology Market (by Device), $Million, 2017-2027
Figure 6.4 Cardiac Catheterisation Laboratories Interventional Cardiology Market (by Device), $Million, 2017-2027
Figure 6.5 Ambulatory Surgical Centres Interventional Cardiology Market (by Device), $Million, 2017-2027
Figure 6.6 Others Segment Interventional Cardiology Market (by Device), $Million, 2017-2027
Figure 7.1 Global Interventional Cardiology Market (by Region and Sub-segment)
Figure 7.2 Global Interventional Cardiology Market (by Region), 2017-2027
Figure 7.3 North America Interventional Cardiology Market, 2017-2027
Figure 7.4 North America Interventional Cardiology Market (by Country), 2017-2027
Figure 7.5 North America Interventional Cardiology Market (by Device), 2017-2027
Figure 7.6 North America Advanced Interventional Cardiology Market (by Device), 2017-2027
Figure 7.7 The U.S. Interventional Cardiology Market, 2017-2027
Figure 7.8 The U.S. Interventional Cardiology Market (by Device), 2017-2027
Figure 7.9 Canada Interventional Cardiology Market, 2017-2027
Figure 7.10 Canada Interventional Cardiology Market (by Devices), 2017-2027
Figure 7.11 Europe Interventional Cardiology Market, 2017-2027
Figure 7.12 Europe Interventional Cardiology Market (by Country), 2017-2027
Figure 7.13 Europe Interventional Cardiology Market (by Devices), 2017-2027
Figure 7.14 Europe Advanced Interventional Cardiology Market (by Devices), 2017-2027
Figure 7.15 Germany Interventional Cardiology Market, 2017-2027
Figure 7.16 Germany Interventional Cardiology Market (by Device), 2017-2027
Figure 7.17 France Interventional Cardiology Market, 2017-2027
Figure 7.18 France Interventional Cardiology Market (by Device), 2017-2027
Figure 7.19 The U.K. Interventional Cardiology Market, 2017-2027
Figure 7.20 The U.K. Interventional Cardiology Market (by Device), 2017-2027
Figure 7.21 Italy Interventional Cardiology Market, 2017-2027
Figure 7.22 Italy Interventional Cardiology Market (by Device), 2017-2027
Figure 7.23 Spain Interventional Cardiology Market, 2017-2027
Figure 7.24 Spain Interventional Cardiology Market (by Device), 2017-2027
Figure 7.25 Netherlands Interventional Cardiology Market, 2017-2027
Figure 7.26 Netherlands Interventional Cardiology Market (by Device), 2017-2027
Figure 7.27 Switzerland Interventional Cardiology Market, 2017-2027
Figure 7.28 Switzerland Interventional Cardiology Market (by Device), 2017-2027
Figure 7.29 Belgium Interventional Cardiology Market, 2017-2027
Figure 7.30 Belgium Interventional Cardiology Market (by Device), 2017-2027
Figure 7.31 Sweden Interventional Cardiology Market, 2017-2027
Figure 7.32 Sweden Interventional Cardiology Market (by Device), 2017-2027
Figure 7.33 Austria Interventional Cardiology Market, 2017-2027
Figure 7.34 Austria Interventional Cardiology Market (by Device), 2017-2027
Figure 7.35 Rest-of-Europe Interventional Cardiology Market, 2017-2027
Figure 7.36 Rest-of-Europe Interventional Cardiology Market, 2017-2027
Figure 7.37 Asia-Pacific Interventional Cardiology Market, 2017-2027
Figure 7.38 Asia-Pacific Interventional Cardiology Market (by Country), 2017-2027
Figure 7.39 Asia-Pacific Interventional Cardiology Market (by Device), 2017-2027
Figure 7.40 Asia-Pacific Advanced Interventional Cardiology Market (by Device), 2017-2027
Figure 7.41 Japan Interventional Cardiology Market, 2017-2027
Figure 7.42 Japan Interventional Cardiology Market (by Device), 2017-2027
Figure 7.43 China Interventional Cardiology Market, 2017-2027
Figure 7.44 China Interventional Cardiology Market (by Device), 2017-2027
Figure 7.45 Sotuh Korea Interventional Cardiology Market, 2017-2027
Figure 7.46 South Korea Interventional Cardiology Market (by Device), 2017-2027
Figure 7.47 Australia Interventional Cardiology Market, 2017-2027
Figure 7.48 Australia Interventional Cardiology Market (by Device), 2017-2027
Figure 7.49 India Interventional Cardiology Market, 2017-2027
Figure 7.50 India Interventional Cardiology Market (by Device), 2017-2027
Figure 7.51 Malaysia Interventional Cardiology Market, 2017-2027
Figure 7.52 Malaysia Interventional Cardiology Market (by Device), 2017-2027
Figure 7.53 Singapore Interventional Cardiology Market, 2017-2027
Figure 7.54 Singapore Interventional Cardiology Market (by Device), 2017-2027
Figure 7.55 Taiwan Interventional Cardiology Market, 2017-2027
Figure 7.56 Taiwan Interventional Cardiology Market (by Device), 2017-2027
Figure 7.57 Rest-of-APAC Interventional Cardiology Market, 2017-2027
Figure 7.58 Rest-of-APAC Interventional Cardiology Market (by Device), 2017-2027
Figure 7.59 Latin America Interventional Cardiology Market, 2017-2027
Figure 7.60 Latin America Interventional Cardiology Market (by Country), 2017-2027
Figure 7.61 Latin America Interventional Cardiology Market (by Device), 2017-2027
Figure 7.62 Latin America Advanced Interventional Cardiology Market (by Device), 2017-2027
Figure 7.63 Brazil Interventional Cardiology Market, 2017-2027
Figure 7.64 Brazil Interventional Cardiology Market (by Device), 2017-2027
Figure 7.65 Mexico Interventional Cardiology Market, 2017-2027
Figure 7.66 Mexico Interventional Cardiology Market (by Device), 2017-2027
Figure 7.67 Rest-of-Latin America Interventional Cardiology Market, 2017-2027
Figure 7.68 Rest-of-Latin America Interventional Cardiology Market (by Device), 2017-2027
Figure 7.69 RoW Interventional Cardiology Market, 2017-2027
Figure 7.70 RoW Interventional Cardiology Market (by Country), 2017-2027
Figure 7.71 RoW Interventional Cardiology Market (by Device), 2017-2027
Figure 7.72 RoW Advanced Interventional Cardiology Market (by Device), 2017-2027
Figure 7.73 Russia Interventional Cardiology Market, 2017-2027
Figure 7.74 Russia Interventional Cardiology Market (by Device), 2017-2027
Figure 7.75 K.S.A. Interventional Cardiology Market, 2017-2027
Figure 7.76 K.S.A. Interventional Cardiology Market (by Device), 2017-2027
Figure 7.77 South Africa Interventional Cardiology Market, 2017-2027
Figure 7.78 South Africa Interventional Cardiology Market (by Device), 2017-2027
Figure 7.79 Others Interventional Cardiology Market, 2017-2027
Figure 7.80 Others Interventional Cardiology Market (by Device), 2017-2027
Figure 8.1 Share of Public and Private Companies
Figure 8.2 ABIOMED, Inc.: Cardiac Interventions Product Portfolio
Figure 8.3 ABIOMED, Inc.: Overall Financials 2016-2018
Figure 8.4 ABIOMED, Inc.: Net Revenue by Business Segments (2016-2018)
Figure 8.5 ABIOMED, Inc.: Net Revenue (by Region) 2016-2018
Figure 8.6 ABIOMED, Inc.: Global Presence
Figure 8.7 ABIOMED, Inc.: SWOT Analysis
Figure 8.8 ACIST Medical Systems, Inc.: Cardiac Interventions Product Portfolio
Figure 8.9 ACIST Medical Systems, Inc.: Global Presence
Figure 8.10 ACIST Medical Systems, Inc.: SWOT Analysis
Figure 8.11 B. Braun Melsugen AG: Product/Service Offerings
Figure 8.12 B. Braun Melsugen AG: Overall Product Portfolio
Figure 8.14 B. Braun Melsugen AG: Overall Financials (2015-2017)
Figure 8.15 B. Braun Melsugen AG: Revenue (by Division) 2015-2017
Figure 8.16 B. Braun Melsugen AG: Net Revenue by Region (2015-2017)
Figure 8.17 B. Braun Melsungen AG: Global Presence
Figure 8.18 B. Braun Melsungen AG: SWOT Analysis
Figure 8.19 Biotronik SE & Co. KG: Product/Service Offerings
Figure 8.20 Biotronik SE & Co. KG: Cardiac Interventions Product Portfolio
Figure 8.21 Biotronik SE & Co. KG: Global Presence
Figure 8.22 Biotronik SE & Co. KG: SWOT Analysis
Figure 8.23 Boston Scientific Corporation: Product/Service Offerings
Figure 8.24 Boston Scientific Corporation: Cardiac Interventions Product Portfolio
Figure 8.25 Boston Scientific Corporation: Overall Financials 2014-2017
Figure 8.26 Boston Scientific Corporation: Net revenue (by Business Segment) 2014-2017
Figure 8.27 Boston Scientific Corporation: Net Revenue (by Region) 2014-2017
Figure 8.28 Boston Scientific Corporation: Global Presence
Figure 8.29 Boston Scientific Corporation: SWOT Analysis
Figure 8.30 Becton, Dickinson and Company: Overall Product/Service Offerings
Figure 8.31 Becton, Dickinson & Company: Cardiac Interventions Product Portfolio
Figure 8.32 Becton, Dickinson and Company: Overall Financials 2015-2017
Figure 8.33 Becton, Dickinson and Company: Revenue (by Business Segment) 2015-2017
Figure 8.34 Becton, Dickinson and Company: Revenue (by Region) 2015-2017
Figure 8.35 Becton, Dickinson, and Company: Global Presence
Figure 8.36 Becton, Dickinson and Company: SWOT Analysis
Figure 8.37 Cook Medical LLC: Product/Service Offerings
Figure 8.38 Cook Medical LLC: Cardiac Interventions Product Portfolio
Figure 8.39 Cook Medical LLC: Global Presence
Figure 8.40 Cook Medical LLC: SWOT Analysis
Figure 8.41 Cardinal Health, Inc.: Product/Service Offerings
Figure 8.42 Cardinal Health, Inc.: Cardiac Interventions Product Portfolio
Figure 8.43 Cardinal Health, Inc.: Overall Financials, 2015-2017
Figure 8.44 Cardinal Health, Inc.: Net Revenues (by Business Segments), 2015-2027
Figure 8.45 Cardinal Health, Inc.: Net Revenue (by Region0, 2015-2017
Figure 8.46 Cardinal Health, Inc.: Global Presence
Figure 8.47 Cardinal Health, Inc.: SWOT Analysis
Figure 8.48 Edwards Lifesciences Corporation: Product/Service Offerings
Figure 8.49 Edwards Lifesciences Corporation: Cardiac Interventions Product Portfolio
Figure 8.50 Edwards Lifesciences Corporation: Overall Financials 2015-2017
Figure 8.51 Edwards Lifesciences Corporation: Net Sales (by Product Segment) 2015-2017
Figure 8.52 Edwards Lifesciences Corporation: Net Sales (by Region) 2015-2017
Figure 8.53 Edwards Lifesciences Corporation: Global Presence
Figure 8.54 Edwards Lifesciences Corporation: SWOT Analysis
Figure 8.55 Life Vascular Devices Biotech S.L.: Product/Service Offerings
Figure 8.56 Life Vascular Devices Biotech S.L.: Cardiac Interventions Product Portfolio
Figure 8.57 Life Vascular Devices Biotech S.L.: Global Presence
Figure 8.58 Life Vascular Devices Biotech S.L.: SWOT Analysis
Figure 8.59 Johnson & Johnson Services, Inc.: Product/Service Offerings
Figure 8.60 Johnson & Johnson Services, Inc.: Cardiac Interventions Product Portfolio
Figure 8.61 Johnson & Johnson Services, Inc.: Overall Financials 2014-2017
Figure 8.62 Johnson & Johnson Services, Inc.: Net Sales (by Business Segments) 2014-2017
Figure 8.63 Johnson & Johnson Services, Inc.: Net Sales (by Region) 2014-2016
Figure 8.64 Johnson & Johnson Services, Inc.: Net Sales (by Region), 2017
Figure 8.65 Johnson & Johnson Services, Inc.: Net Revenue (by Medical Devices Business Segment) 2014-2017
Figure 8.66 Johnson & Johnson Services, Inc.: Global Presence
Figure 8.67 Johnson & Johnson Services, Inc.: SWOT Analysis
Figure 8.68 Medtronic Plc: Product/Service Offerings
Figure 8.69 Medtronic Plc: Cardiac Interventions Product Portfolio
Figure 8.70 Medtronic Plc: Overall Financials 2014-2017
Figure 8.71 Medtronic Plc: Net Revenue by Business Segment (2014-2017)
Figure 8.72 Medtronic Plc: Net Revenue (by Region) 2014-2017
Figure 8.73 Medtronic Plc: Global Presence
Figure 8.74 Medtronic Plc: SWOT Analysis
Figure 8.75 Merit Medical Systems, Inc: Product/Service Offerings
Figure 8.76 Merit Medical Systems, Inc: Cardiac Interventions Product Portfolio
Figure 8.77 Merit Medical Systems, Inc: Overall Financials 2014-2017
Figure 8.78 Merit Medical Systems, Inc: Net Revenue (by Business Segment) 2014-2017
Figure 8.79 Merit Medical Systems, Inc: Global Presence
Figure 8.80 Merit Medical Systems, Inc: SWOT Analysis
Figure 8.81 Novacam Technologies Inc.: Product/Service Offerings
Figure 8.82 Novacam Technologies Inc.: Cardiac Interventions Product Portfolio
Figure 8.83 Novacam Technologies Inc.: Global Presence
Figure 8.84 Novacam Technologies Inc.: SWOT Analysis
Figure 8.85 Koninklijke Philips N.V.: Product/Service Offerings
Figure 8.86 Koninklijke Philips N.V.: Cardiac Interventions Product Portfolio
Figure 8.87 Koninklijke Philips N.V.: Overall Financials (2015-2017)
Figure 8.88 Koninklijke Philips N.V.: Net Revenues (by Business Segments) 2015-2017
Figure 8.89 Koninklijke Philips N.V.: Net Revenue (by Region) 2015-2017
Figure 8.90 Koninklijke Philips N.V.: Global Presence
Figure 8.91 Koninklijke Philips N.V.: SWOT Analysis
Figure 8.92 Abbott Laboratories: Product/Service Offerings
Figure 8.93 Abbott Laboratories: Cardiac Interventions Product Portfolio
Figure 8.94 Abbott Laboratories: Overall Financials 2014-2017
Figure 8.95 Abbott Laboratories: Revenue (by Business Segment) 2014-2017
Figure 8.96 Abbott Laboratories: Revenue (by Region) 2014-2017
Figure 8.97 Abbott Laboratories: Revenue by Cardiovascular and Neuromodulation Segment (2017)
Figure 8.98 Abbott Laboratories: Global Presence
Figure 8.99 Abbot Laboratories: SWOT Analysis
Figure 8.100 Terumo Corporation: Product/Service Offerings
Figure 8.101 Terumo Corporation: Cardiac Interventions Product Portfolio
Figure 8.102 Terumo Corporation: Overall Financials 2015-2017
Figure 8.103 Terumo Corporation: Revenue (by Business Segment) 2015-2017
Figure 8.104 Terumo Corporation: Net Revenue (by Region) 2015-2017
Figure 8.105 Terumo Corporation: Global Presence
Figure 8.106 Terumo Corporation: SWOT Analysis
Figure 8.107 W. L. Gore & Associates, Inc.: Product/Service Offerings
Figure 8.108 W. L. Gore & Associates Inc.: Cardiac Interventions Product Portfolio
Figure 8.109 W. L. Gore & Associates, Inc.: Global Presence
Figure 8.110 W. L. Gore & Associates, Inc.: SWOT Analysis
Figure 8.111 Biosensors International Group, Ltd.: Cardiac Interventions Product Portfolio
Figure 8.112 GE Healthcare: Cardiac Interventions Product Portfolio
Figure 9.1 Global Interventional Cardiology Market Segmentation
Figure 9.2 Research Methodology
Figure 9.3 Key Data Points from Primary and Secondary Sources
Figure 9.4 Data Triangulation
Figure 9.5 Top-down Approach: Global Interventional Cardiology Market
Figure 9.6 Bottom-up Approach: Global Interventional Cardiology Market
Figure 9.7 Assumptions and Limitations
Market Overview
Rising economic burden of chronic diseases is one of the prime concerns that the healthcare and biomedical device industries are currently facing. The high prevalence of chronic diseases such as as cancer, diabetes, cardiovascular diseases, and respiratory diseases, among others, poses one of the significant challenges across the globe. Furthermore, change in eating habits, increased stress, smoking, alcohol consumption, and disturbed sleeping patterns are some of the key factors contributing to the deteriorating health condition in individuals and a rise in lifestyle disorders. It has been estimated that chronic diseases constitute approximately 43% of the global economic burden for diseases and accounts for 60% of the deaths worldwide. It further holds approximately 65% of the annual healthcare cost of any country and comprises one-third of the global population at present. By 2020, the global spending on diseases such as cardiovascular diseases, cancer, and respiratory diseases is expected to reach $4 trillion. Moreover, growing geriatric population has resulted in increased prevalence of lifestyle disease that has led to an upsurge in the demand for advanced medical diagnosis and treatment.
Cardiovascular diseases (CVDs) represent the leading cause of death globally. According to the World Health Organization (WHO), CVD was estimated to claim 17.3 million lives, a number which is anticipated to grow to 23.6 million by 2030. Of these, coronary artery disease and stroke resulted in approximately 7.4 million deaths and 6.7 million deaths respectively. Interventional cardiology deals with the treatment of structural heart diseases specially employing the use of interventional catheters. It involves the treatment of coronary artery disease, heart valve disease, and peripheral vascular disease, among others. With increase in the prevalence of cardiac diseases, advanced interventional cardiology devices are gradually becoming an integral part of the medical device industry.
The purpose of the study is to gain a holistic view of the advanced cardiac intervention market in terms of various factors influencing it such as recent trends and technological advancements of the market. The scope of this report is centered upon conducting a detailed study of the devices allied with the cardiac interventional devices market, which includes both conventional devices and imaging modalities. The global advanced cardiac intervention market is segmented into three different parts: devices, end users, and geography. The global market value was estimated using these three different approaches and was validated with one another. These segments are further segmented into several sub-segments to ease the market estimation.
The global interventional cardiology market was estimated at $14.69 billion in 2017 and is anticipated to reach $24.96 billion by 2027. With the rise in the demand for advanced medical devices to treat cardiovascular diseases, increasing geriatric population with higher life expectancy, and new product launches by several conglomerate companies, the cardiac intervention market is expected to witness moderate growth. The emergence of advanced imaging modalities such as IntraVenous UltraSound (IVUS), Optical Coherent Tomography (OCT), and Fractional Flow Reserve (FFR) has led to the growth of the market.
The global interventional cardiology is segmented by the geographical regions into North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World (RoW). North America is the leading contributor to the global interventional cardiology market. However, the Asia-Pacific is expected to grow at a CAGR of 7.12% in the forecast period 2018-2027. The global interventional cardiology market for advanced devices is majorly dominated by the U.S. and the European players.
The key players who have significant contributions to the global interventional cardiology market are Abiomed, Inc., ACIST Medical Systems, Inc., B. Braun Melsungen AG, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cook Medical LLC, Cordis Corporation, Edwards Lifesciences Corporation, GE Healthcare, Life Vascular Devices Biotech S.L., Biostense Webster, Inc., Medtronic Plc, Merit Medical Systems, Inc., Novacam Technologies Inc., Koninklijke Philips N.V., St. Jude Medical, Terumo Corporation, and W.L. Gore & Associates, Inc., among others.
Report Description
Cardiovascular diseases are the major cause of death across the globe. It accounted for 17.3 million deaths in 2015 and is further anticipated to claim 23.6 million lives in 2030 (according to an estimation by the World Health Organization). The rise in geriatric population worldwide has resulted in an increased prevalence of the disease. Moreover, change in eating habits, increased stress, smoking, and alcohol consumption, and disturbed sleeping patterns are some of the key factors contributing to the deteriorating health conditions and to the rise in chronic diseases such as diabetes and cardiac diseases. The International Diabetes Federation has estimated that approximately 415 million people were diabetic in 2015 while the number is expected rise to 642 million worldwide by 2040. Therefore, increased incidence of cardiac diseases accompanied by the rise in healthcare expenditure in the medical device industry are expected to lead the growth of the interventional cardiology market.
The interventional cardiology devices industry is a multi-billion-dollar market which consists of multitudinous companies involved in the manufacturing of catheters, stents, valves, angioplasty balloons, and other cardiac interventional instruments to meet the increasing demand of people suffering from cardiovascular disorders. The advanced cardiac intervention market provides treatment option for a range of cardiovascular diseases including coronary artery disease, heart valve disease, and peripheral vascular disease, among others.
The purpose of this study is to gain a holistic view of the interventional cardiology market in terms of various influencing factors such as recent trends and technological advancements. The scope of this report constitutes of an in-depth study of the global interventional cardiology market, including a thorough analysis of the products across different regions. The market has been segmented into ‘devices’, ‘end users’, and ‘regions’. The ‘devices’ segment consists of both conventional and advanced devices. Advanced devices cover the technologically advanced imaging modalities such as IntraVenous UltraSound (IVUS), Fractional Flow Reserve (FFR), and Optical Coherent Tomography (OCT). The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.
This research report aims at answering various aspects of the global interventional cardiology market with the help of the key factors driving the market, restraints that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key ecosystem players and key strategies and developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities, and challenges) and industry analysis as well.
The research study considers the market share analysis for a comprehensive understanding of the global interventional cardiology market, and assesses the factors governing the same. Detailed product mapping have been included in the report. The market (by region) has been further sub-segmented in various countries, and in each sub-segment the key market trends, list of the key players, and the recent developments that have taken place, have been discussed.
The key players who have been contributing significantly to the interventional cardiology market include Abiomed, Inc., ACIST Medical Systems, Inc., B. Braun Melsungen AG, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cook Medical LLC, Cordis Corporation, Edwards Lifesciences Corporation, GE Healthcare, Life Vascular Devices Biotech S.L., Biostense Webster, Inc., Medtronic Plc, Merit Medical Systems, Inc., Novacam Technologies Inc., Koninklijke Philips N.V., St. Jude Medical, Terumo Corporation, and W.L. Gore & Associates, Inc., among others.
Key Questions Answered in this Report:
• What are the major market drivers, challenges, and opportunities in the global interventional cardiology market?
• What was the market value of the leading segments and sub-segments of the global interventional cardiology market in 2017?
• How will each segment of the global interventional cardiology market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2027?
• What are the influencing factors that may affect the market share of the key players?
• How will the industry evolve during the forecast period 2018-2027?
• What are the key developmental strategies that are implemented by the key players to sustain in this market?
• Who are the key players in the interventional cardiology devices and end user market and what are their contributions?
• What are the major benefits of the implementation of interventional cardiology in different fields of applications including angioplasty, stent placement, coronary thrombectomy, valvuloplasty, percutaneous valve repair or replacement, and congenital heart abnormalities?
• What is the scope of interventional cardiology in the emerging economies of Asia-Pacific and Latin America?
• What is the scope for expansion by the key players of the interventional cardiology market in the developed countries of North America and Europe?
Global Interventional Cardiology Market
Focus on Devices (Conventional and Advanced), End Users, and Regions- Analysis and Forecast, 2018-2027
Similar Product
You may also like
Published Year: 2017
Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market - Analysis and Forecast,
The global pacemakers and ICDs market are expected to grow at a CAGR of 4.6% and 4.8% from...